U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Wed Apr 02 01:58:28 GMT 2025
Edited
by admin
on Wed Apr 02 01:58:28 GMT 2025
Protein Sub Type
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
4K108E14CS
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 8
Common Name English
CD-30
Preferred Name English
LYMPHOCYTE ACTIVATION ANTIGEN CD30
Common Name English
D1S166E
Common Name English
KI-1 ANTIGEN
Common Name English
CD30
Common Name English
Code System Code Type Description
PHAROS
P28908
Created by admin on Wed Apr 02 01:58:28 GMT 2025 , Edited by admin on Wed Apr 02 01:58:28 GMT 2025
PRIMARY
UNIPROT
P28908
Created by admin on Wed Apr 02 01:58:28 GMT 2025 , Edited by admin on Wed Apr 02 01:58:28 GMT 2025
PRIMARY
FDA UNII
4K108E14CS
Created by admin on Wed Apr 02 01:58:28 GMT 2025 , Edited by admin on Wed Apr 02 01:58:28 GMT 2025
PRIMARY
From To
1_11 1_26
1_27 1_40
1_30 1_47
1_51 1_63
1_66 1_80
1_69 1_88
1_90 1_104
1_113 1_131
1_215 1_222
1_226 1_238
1_241 1_255
1_244 1_263
1_265 1_279
1_271 1_282
Glycosylation Type HUMAN
Glycosylation Link Type Site
N 1_83
N 1_258
Related Record Type Details
CONJUGATED TOXIN->TARGET
LIGAND->TARGET
Anti-CD30 monoclonal antibody XmAb2513 specifically binds to the CD30 antigen, which may result in a cytotoxic T lymphocyte (CTL) response against CD30-expressing tumor cells.
LIGAND->TARGET
INHIBITOR -> TARGET
LIGAND->TARGET
Determined by Surface Plasmon Resonance (SPR).

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO ACID SUBSTITUTION [1_434]
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT CHEMICAL